Patents Assigned to GENESIS GENOMICS, INC.
  • Publication number: 20130022979
    Abstract: The present invention broadly claims a method for detecting cancer in an individual. The method comprises detecting a deletion in the nucleic acid sequence between residues 10743 and 12125 in mitochondrial DNA. The method comprises obtaining a biological sample from the individual; extracting the mitochondrial DNA (mtDNA) from the sample; quantifying the amount of mtDNA in the sample having a deletion in the nucleic acid sequence between residues 10743 and 14125 of the mtDNA genome; and comparing the amount of mtDNA in the sample having the deletion to at least one known reference sample.
    Type: Application
    Filed: March 26, 2010
    Publication date: January 24, 2013
    Applicant: GENESIS GENOMICS INC.
    Inventors: Ryan Parr, Robert Thayer, Gabriel Dakubo, Jennifer Creed, Kerry Robinson, Andrea Maggrah, Brian Reguly
  • Publication number: 20090192047
    Abstract: Mitochondrial DNA deletions useful for the detection of cancers and sun exposure are provided. In particular, methods and kits for detecting mitochondrial DNA deletions for the early detection, diagnosis and progression of prostate cancer, sun exposure and non-melonoma skin cancer are provided.
    Type: Application
    Filed: October 18, 2007
    Publication date: July 30, 2009
    Applicant: GENESIS GENOMICS, INC.
    Inventors: Ryan Parr, Robert Thayer, Gabriel Dakubo, Jennifer Maki, Kerry Robinson, Andrea Maggrah, Brian Reguly, Andrew Harbottle, Mark Birch-Machin